"Dec. 18, 2012 -- Taking aspirin regularly appears to slightly raise the risk of the eye condition known as age-related macular degeneration or AMD, new research suggests.
The increased risk only occurred with people who had taken aspi"...
(levobetaxolol hydrochloride) Ophthalmic Suspension 0.5%
Sterile Topical Ophthalmic Drops
BETAXON™ (levobetaxolol hydrochloride ophthalmic suspension) 0.5% contains levobetaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile resin suspension formulation. Levobetaxolol hydrochloride is a white, crystalline powder with a molecular weight of 343.89. The specific rotation is:
[α]25°C/589nm -19.67°(c=20 mg/mL; methanol)
The chemical structure is:
Empirical Formula: C18H29NO3•HCl
Chemical Name: (S)-1-[p-[2-(cyclopropylemethoxy)ethyl]phenoxy]3-(isopropylamino)-2-propanol hydrochloride.
Each mL of BETAXON™ (levobetaxolol hydrochloride ophthalmic suspension) 0.5% contains: Active: levobetaxolol HCl 5.6 mg equivalent to 5.0 mg of levobetaxolol free base. Preservative: benzalkonium chloride 0.01%. Inactives: mannitol, poly(styrene-divinyl benzene) sulfonic acid, Carbomer 974P, boric acid, N-lauroylsarcosine, edetate disodium, hydrochloric acid or tromethamine (to adjust pH) and purified water. It has a pH of 5.5 to 7.5 and an osmolality of 260 to 340 mOsm per kg.
Last reviewed on RxList: 3/30/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Betaxon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.